Hematology This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

Leukocyte cell population data (volume conductivity scatter) in postprandial leukocyte activation
ConclusionPostprandial leukocyte activation is accompanied by temporary changes in leukocyte cell population data, similar to changes observed during various infections, but to a lesser extent. (Source: Clinical and Laboratory Haematology)
Source: Clinical and Laboratory Haematology - May 15, 2013 Category: Hematology Authors: B. Klop, G.‐J. M. Geijn, T. L. Njo, H. W. Janssen, A. P. Rietveld, A. Miltenburg, L. Fernández‐Sender, J. W. F. Elte, M. Castro Cabezas Tags: Original Article Source Type: research

Novel deep intronic and missense UNC13D mutations in familial haemophagocytic lymphohistiocytosis type 3
(Source: British Journal of Haematology)
Source: British Journal of Haematology - May 15, 2013 Category: Hematology Authors: Miriam Entesarian, Samuel C. C. Chiang, Heinrich Schlums, Marie Meeths, Mei‐Yoke Chan, Soe‐Nwe Mya, Shui‐Yen Soh, Magnus Nordenskjöld, Jan‐Inge Henter, Yenan T. Bryceson Tags: Correspondence Source Type: research

FDA OKs Test for Use with Tarceva
WASHINGTON (MedPage Today) -- The FDA has approved a companion EGFR mutation test for use with the targeted cancer drug erlotinib (Tarceva) to help guide decision making in non-small cell lung cancer. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 14, 2013 Category: Hematology Source Type: news

FDA Approves Companion Genetic Diagnostic Test for TarcevaFDA Approves Companion Genetic Diagnostic Test for Tarceva
The FDA has approved the first companion diagnostic test that can detect EGFR mutations in non-small cell lung cancer. FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 14, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Angelina's Mastectomy: Oncologists Respond
(MedPage Today) -- When Angelina Jolie charted her course of action against the breast cancer cards she'd been dealt, she didn't seek direction from an academic medical center. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 14, 2013 Category: Hematology Source Type: news

New Therapy Unleashes 'Serial Killer' Cells in LeukemiaNew Therapy Unleashes 'Serial Killer' Cells in Leukemia
Adoptive immunotherapy is providing exciting preliminary results in leukemia patients. Leading researcher Dr. Carl June explains the therapy and its potential application to other cancers. Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 14, 2013 Category: Consumer Health News Tags: Hematology-Oncology Expert Interview Source Type: news

Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis
Abstract: Multiple intracellular signaling pathways, such as Wnt/β-catenin signaling, epidermal growth factor receptor/Ras signaling, and p53 signaling are frequently dysregulated in colorectal cancer. Recent evidence also points to the involvement of signaling pathways in the developmental process, including Notch signaling, Hedgehog signaling, and Hippo signaling. Dysregulation of these signaling pathways contribute to the acquisition of malignant phenotypes, including unchecked cell cycle progression, evasion of apoptosis, induction of genetic instability, and enhanced invasiveness and metastasis. Understanding their r...
Source: Critical Reviews in Oncology Hematology - May 14, 2013 Category: Cancer & Oncology Authors: William K.K. Wu, Xiao J. Wang, Alfred S.L. Cheng, Millore X.M. Luo, Simon S.M. Ng, Ka F. To, Francis K.L. Chan, Chi H. Cho, Joseph J.Y. Sung, Jun Yu Source Type: research

Editorial Board
(Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - May 14, 2013 Category: Cancer & Oncology Source Type: research

Anti-angiogenesis in neuroblastoma
Abstract: The nature of the angiogenic balance in neuroblastoma is complex, and a spectrum of angiogenesis stimulators and inhibitors have been detected in neuroblastoma tumours. The complex relationships between angiogenic cascade and anti-angiogenic agents in the tumour vascular phase have indicated that anti-angiogenesis can be considered as a strategy for the adjuvant therapy of neuroblastoma. The major goal is to establish if inhibition of angiogenesis is a realistic therapeutic strategy for inhibiting tumour cell dissemination and the formation of metastasis in neuroblastoma. (Source: Critical Reviews in Oncology Hematology)
Source: Critical Reviews in Oncology Hematology - May 14, 2013 Category: Cancer & Oncology Authors: Domenico Ribatti Source Type: research

Creative Arts Therapies Improve QOL in Cancer PatientsCreative Arts Therapies Improve QOL in Cancer Patients
Creative arts therapies decrease symptoms such as pain, depression, and anxiety and improve quality of life (QOL) in cancer patients, according to an analysis. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 14, 2013 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia
Summary Fetal neonatal alloimmune thrombocytopenia (FNAIT) is a devastating bleeding disorder in the fetus or neonate caused by transplacental transport of maternal alloantibodies to paternal‐derived antigen on fetal platelets. In Caucasians, up to 80% of FNAIT cases result from maternal immunization to human platelet antigen (HPA)‐1a. New methods have developed facilitating detection of common and private antibodies against HPAs triggering FNAIT. Understanding the pathogenesis of FNAIT made it possible to develop a novel strategy to treat this disorder. To date, recombinant monoclonal antibodies directed against the �...
Source: British Journal of Haematology - May 14, 2013 Category: Hematology Authors: Ophira Salomon, Nurit Rosenberg Tags: State of the Art Review Source Type: research

The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis
(Source: British Journal of Haematology)
Source: British Journal of Haematology - May 14, 2013 Category: Hematology Authors: Maria C. Susini, Paola Guglielmelli, Ambra Spolverini, Flavia Biamonte, Carmela Mannarelli, Giovanni Barosi, Katerina Zoi, Andreas Reiter, Andrew Duncombe, Francisco Cervantes, Mario Cazzola, Nick Cross, Alessandro M. Vannucchi, Tags: Correspondence Source Type: research

Thrombospondin‐1 and L‐selectin are associated with silent cerebral infarct in children with sickle cell anaemia
(Source: British Journal of Haematology)
Source: British Journal of Haematology - May 14, 2013 Category: Hematology Authors: Lisa M. Faulcon, Zongming Fu, Pratima Dulloor, Emily Barron‐Casella, William Savage, Jacky M. Jennings, Jennifer E. Eyk, Michael DeBaun, James F. Casella, Allen Everett Tags: Correspondence Source Type: research

Health‐related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy
Summary Patients with myelofibrosis (MF) have significant debilitating symptoms, physical disabilities, and poor health‐related quality of life (HRQoL). Here, we report post‐hoc analyses of the impact of ruxolitinib, a potent and selective JAK1 and JAK2 inhibitor, on disease‐related symptoms and HRQoL in MF patients from the large phase 3 COMFORT‐II study (N = 219). During the follow‐up period of 48 weeks, HRQoL and MF‐associated symptoms improved from baseline for ruxolitinib‐treated patients but remained the same or worsened for best available therapy (BAT)‐treated patients. Based on the European Organ...
Source: British Journal of Haematology - May 14, 2013 Category: Hematology Authors: Claire N. Harrison, Ruben A. Mesa, Jean‐Jacques Kiladjian, Haifa‐Kathrin Al‐Ali, Heinz Gisslinger, Laurent Knoops, Margaret Squier, Andres Sirulnik, Estella Mendelson, Xiaolei Zhou, Catherine Copley‐Merriman, Deborah S. Hunter, Richard S. Levy, Fr Tags: Research Paper Source Type: research

The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab
(Source: British Journal of Haematology)
Source: British Journal of Haematology - May 14, 2013 Category: Hematology Authors: Charles Alderman, Jonathan Corlett, Jonathan Cullis Tags: Correspondence Source Type: research

Longer follow‐up confirms major improvement in outcome in children and adolescents with Philadelphia chromosome acute lymphoblastic leukaemia treated with continuous imatinib and haematopoietic stem cell transplantation. Results from the Spanish Cooperative Study SHOP/ALL‐2005
(Source: British Journal of Haematology)
Source: British Journal of Haematology - May 14, 2013 Category: Hematology Authors: Susana Rives, Mireia Camós, Jesús Estella, Pedro Gómez, Mª José Moreno, José Luis Vivanco, Montserrat Melo, Rafael Fernández‐Delgado, Amparo Verdeguer, Ana Fernández‐Teijeiro, Francisco Lendínez, Ricardo López‐Almaraz, José Javier Uriz, I Tags: Correspondence Source Type: research

rs2072135, a low‐penetrance variant for chronic lymphocytic leukaemia?
Summary Recent multi‐stage genome‐wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) that are robustly associated with chronic lymphocytic leukaemia (CLL) risk. Given that most of these SNPs map to non‐coding regions of the genome, it suggests that the functional basis of many GWAS signals will be through differential gene expression. By referencing publically accessible expression quantitative trait loci (eQTL) data on lymphoblastoid cells lines (LCLs) we have globally demonstrated an association between GWAS P‐values and eQTLs, consistent with much of the variation in CLL risk ...
Source: British Journal of Haematology - May 14, 2013 Category: Hematology Authors: Georgina P. Sava, Helen E. Speedy, Maria Chiara Bernardo, Silvia Deaglio, Lidia Karabon, Irena Frydecka, Dariusz Woszczyk, Davide Rossi, Gianluca Gaidano, Larry Mansouri, Karin E. Smedby, Gunnar Juliusson, Richard Rosenquist, Daniel Catovsky, Richard S. H Tags: Research Paper Source Type: research

NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model
NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model Leukemia advance online publication, May 14 2013. doi:10.1038/leu.2013.114 Authors: M Mallardo, A Caronno, G Pruneri, P R Raviele, A Viale, P G Pelicci & E Colombo (Source: Leukemia)
Source: Leukemia - May 14, 2013 Category: Hematology Authors: M MallardoA CaronnoG PruneriP R RavieleA VialeP G PelicciE Colombo Source Type: research

Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis
uño, F Girodon & S Schnittger (Source: Leukemia)
Source: Leukemia - May 14, 2013 Category: Hematology Authors: J BroséusT AlpermannM WulfertL Florensa BrichsS JerominE LippertM RozmanF LifermannV GrossmannT HaferlachU GermingE LuñoF GirodonS Schnittger Tags: refractory anaemia with ring sideroblasts and marked thrombocytosis SF3B1 prognostic impact survival Source Type: research

Multiparameter flow cytometry for the identification of the Waldenström’s clone in IgM-MGUS and Waldenström’s Macroglobulinemia: new criteria for differential diagnosis and risk stratification
Multiparameter flow cytometry for the identification of the Waldenström’s clone in IgM-MGUS and Waldenström’s Macroglobulinemia: new criteria for differential diagnosis and risk stratification Leukemia advance online publication, May 14 2013. doi:10.1038/leu.2013.124 Authors: B Paiva, M C Montes, R García-Sanz, E M Ocio, J Alonso, N de las Heras, F Escalante, R Cuello, A G de Coca, J Galende, J Hernández, M Sierra, A Martin, E Pardal, A Bárez, J Alonso, L Suarez, T J González-López, J J Perez, A Orfao, M-B Vidríales & J F San Miguel (Source: Leukemia)
Source: Leukemia - May 14, 2013 Category: Hematology Authors: B PaivaM C MontesR García-SanzE M OcioJ AlonsoN de las HerasF EscalanteR CuelloA G de CocaJ GalendeJ HernándezM SierraA MartinE PardalA BárezJ AlonsoL SuarezT J González-LópezJ J PerezA OrfaoM-B VidríalesJ F San Miguel Tags: Waldenstrom’s Macroglobulinemia MGUS flow cytometry phenotype plasma cells survival Source Type: research

Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53−/− mouse model and primary human leukemia cells
Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53−/− mouse model and primary human leukemia cells Leukemia advance online publication, May 14 2013. doi:10.1038/leu.2013.125 Authors: J Liu, G Chen, L Feng, W Zhang, H Pelicano, F Wang, M A Ogasawara, W Lu, H M Amin, C M Croce, M J Keating & P Huang (Source: Leukemia)
Source: Leukemia - May 14, 2013 Category: Hematology Authors: J LiuG ChenL FengW ZhangH PelicanoF WangM A OgasawaraW LuH M AminC M CroceM J KeatingP Huang Tags: leukemia p53 TCL1 mouse model drug resistance Source Type: research

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML
nani & A Tefferi (Source: Leukemia)
Source: Leukemia - May 14, 2013 Category: Hematology Authors: R R LabordeM M PatnaikT L LashoC M FinkeC A HansonR A KnudsonR P KetterlingA PardananiA Tefferi Source Type: research

Microfluidic analysis of cellular deformability of normal and oxidatively‐damaged red blood cells
ABSTRACT Microfluidic analysis of blood has potential clinical value for determining normal and abnormal erythrocyte deformability. To determine if a microfluidic device could reliably measure intra‐ and inter‐ personal variations of normal and oxidized human RBC, venous blood samples were collected from repeat donors over time. RBC deformability was defined by the cortical tension (pN/µm), as determined from the threshold pressure required to deform RBC through a 2‐2.5 μm funnel‐shaped constriction. Oxidized RBC were prepared by treatment with phenazine methosulphate (PMS; 50 µM). Analysis of the control and ox...
Source: American Journal of Hematology - May 14, 2013 Category: Hematology Authors: Joanne M. Kwan, Quan Guo, Dana L. Kyluik‐Price, Hongshen Ma, Mark D. Scott Tags: Research Article Source Type: research

Late extramedullary recurrence of adult onset Burkitt's lymphoma mimicking peritoneal carcinomatosis
(Source: American Journal of Hematology)
Source: American Journal of Hematology - May 14, 2013 Category: Hematology Authors: Preetesh Jain, Ohad Benjamini, Ellen Schlette, Deborah A. Thomas, Susan O'Brien Tags: Images in Hematology Source Type: research

White blood cell count and mortality in patients with acute pulmonary embolism
ABSTRACT Although associated with adverse outcomes in other cardiovascular diseases, the prognostic value of an elevated white blood cell (WBC) count, a marker of inflammation and hypercoagulability, is uncertain in patients with pulmonary embolism (PE). We therefore sought to assess the prognostic impact of the WBC in a large, state‐wide retrospective cohort of patients with PE. We evaluated 14,228 patient discharges with a primary diagnosis of PE from 186 hospitals in Pennsylvania. We used random‐intercept logistic regression to assess the independent association between WBC count levels at the time of presentation a...
Source: American Journal of Hematology - May 14, 2013 Category: Hematology Authors: Carmen Venetz, José Labarère, David Jiménez, Drahomir Aujesky Tags: Research Article Source Type: research

New!! Understanding Adherence to Oral Cancer Therapy
Understanding Adherence to Oral Cancer Therapy is intended to help myeloma patients and their healthcare providers work together to overcome any and all obstacles to adherence to safe and effective oral cancer therapy. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - May 14, 2013 Category: Hematology Source Type: news

A New Option for Chemo-Induced Pain?A New Option for Chemo-Induced Pain?
Dr. Alok Khorana reports on a study that examines the use of duloxetine for chemotherapy-induced painful neuropathy. Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 13, 2013 Category: Consumer Health News Tags: Hematology-Oncology Viewpoint Source Type: news

Medicare Cuts Affect 80% of Oncology Practices, Says SurveyMedicare Cuts Affect 80% of Oncology Practices, Says Survey
A new ASCO survey has found that the federal cuts to Medicare are already taking a toll on oncology practices and on patient care. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 13, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Validation of the minimal citrate tube fill volume for routine coagulation tests on ACL TOP 500 CTS®
ConclusionIn our study, we validated the minimal citrate tube fill volumes of 73%, 90% and 63% for PT‐INR, aPTT and fibrinogen, respectively. (Source: Clinical and Laboratory Haematology)
Source: Clinical and Laboratory Haematology - May 13, 2013 Category: Hematology Authors: K. Ver Elst, S. Vermeiren, S. Schouwers, V. Callebaut, W. Thomson, S. Weekx Tags: Original Article Source Type: research

A Stepwise α Thalassemia Screening Strategy in High Prevalence Areas
ConclusionMolecular characterization of α thalassemia is complex due to high sequence homology between the duplicated α globin genes and to the existence of a variety of gene rearrangements (small and large deletions of various sizes) and punctual substitutions (nondeletional alleles). The novelty of our strategy resides, not in the individual technical steps perse but in the reasoned sequential order of their use taking into consideration the hematological phenotype as well.This article is protected by copyright. All rights reserved. (Source: European Journal of Haematology)
Source: European Journal of Haematology - May 13, 2013 Category: Hematology Authors: Salam S. Alkindi, Shoaib Al Zadjali, Shahina A. Daar, Eunice Sindhuvi, Yasser A. Wali, Anil V. Pathare, Suresh Venugopal, Claudine Lapoumeroulie, Alok Srivastava, Rajagopal Krishnamoorthy Tags: Original Article Source Type: research

Late‐onset Pneumocystis jirovecii pneumonia post fludarabine, cyclophosphamide and rituximab: implications for prophylaxis
ConclusionGiven the high rate of late onset PJP, consideration should be given for extended PJP prophylaxis for up to 12 months post FCR, particularly in pretreated patients. Further evaluation of the role of CD4+ monitoring is warranted to quantify risk for disease development and to guide duration of prophylaxis.This article is protected by copyright. All rights reserved. (Source: European Journal of Haematology)
Source: European Journal of Haematology - May 13, 2013 Category: Hematology Authors: Gabrielle M. Haeusler, Monica A. Slavin, John F. Seymour, Senthil Lingaratnam, Benjamin W. Teh, Constantine S. Tam, Karin A. Thursky, Leon J. Worth Tags: Original Article Source Type: research

Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein–Barr virus, and clonality are important predictors of disease progression and regression
ConclusionsHistology, EBV positivity, and monoclonality of IGH are useful for predicting clinical outcomes in patients with RA‐LPD. (Source: European Journal of Haematology)
Source: European Journal of Haematology - May 13, 2013 Category: Hematology Authors: Ayako Ichikawa, Fumiko Arakawa, Junichi Kiyasu, Kensaku Sato, Hiroaki Miyoshi, Daisuke Niino, Yoshizo Kimura, Masanori Takeuchi, Maki Yoshida, Yukinao Ishibashi, Shinji Nakashima, Yasuo Sugita, Osamu Miura, Koichi Ohshima Tags: Original Article Source Type: research

Late mortality after hematopoietic SCT for a childhood malignancy
nberg & P C Nathan (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - May 13, 2013 Category: Hematology Authors: T SchechterJ D PoleD DarmawikartaJ DoyleM AliM EgelerA GassasM S IrwinM GreenbergP C Nathan Tags: pediatric SCT late mortality Source Type: research

Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography
mberti & M Petrini (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - May 13, 2013 Category: Hematology Authors: E BenedettiB BrunoG B McDonaldA PaolicchiF CaraccioloF PapineschiM PelosiniD CampaniS GalimbertiM Petrini Tags: allogeneic transplantation intestinal GVHD contrast-enhanced ultrasound sonography Source Type: research

Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)
N Nishimoto, K Oba & N Masauzi (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - May 13, 2013 Category: Hematology Authors: J TanakaH KanamoriS NishiwakiK OhashiS TaniguchiT EtoH NakamaeK MinagawaK MiyamuraH SakamakiY MorishimaK KatoR SuzukiN NishimotoK ObaN Masauzi Tags: ALL reduced-intensity conditioning myeloablative conditioning allogeneic hematopoietic SCT Source Type: research

Comorbidity burden in patients with chronic GVHD
B Storer, S J Lee & S Mitchell (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - May 13, 2013 Category: Hematology Authors: W A WoodX ChaiD WeisdorfP J MartinC CutlerY InamotoD WolffS Z PavleticJ PidalaJ M PalmerM AroraS AraiM JagasiaB StorerS J LeeS Mitchell Tags: chronic GVHD comorbidities outcomes allogeneic hematopoietic cell transplantation Source Type: research

A specific and sensitive assay for blood levels of glycated CD59: A novel biomarker for diabetes
Conclusions: We report the development and standardization of a novel, sensitive, and specific ELISA for measuring GCD59 in blood. The assay distinguished individuals with diabetes from those without, and showed strong correlation between GCD59 and HbA1c. Because GCD59 likely contributes to the pathogenesis of diabetes complications, measurement of blood levels of GCD59 may be useful in the diagnosis and management of diabetes. (Source: American Journal of Hematology)
Source: American Journal of Hematology - May 13, 2013 Category: Hematology Authors: Pamela Ghosh, Rupam Sahoo, Anand Vaidya, Sonia Cantel, Amol Kavishwar, Allison Goldfine, Neil Herring, Lynn Bry, Michael Chorev, Jose A. Halperin Tags: Research Article Source Type: research

Deferasirox demonstrates a dose‐dependent reduction in liver iron concentration and consistent efficacy across subgroups of non‐transfusion‐dependent thalassemia patients
The 1‐year THALASSA study enrolled 166 patients with various non‐transfusion‐dependent thalassemia (NTDT) syndromes, degrees of iron burden and patient characteristics, and demonstrated the overall efficacy and safety of deferasirox in reducing liver iron concentration (LIC) in these patients. Here, reduction in LIC with deferasirox 5 and 10 mg/kg/day starting dose groups is shown to be consistent across the following patient subgroups—baseline LIC/serum ferritin, age, gender, race, splenectomy (yes/no), and underlying NTDT syndrome (β‐thalassemia intermedia, HbE/β‐thalassemia or α‐thalassemia). These an...
Source: American Journal of Hematology - May 13, 2013 Category: Hematology Authors: Ali T. Taher, John B. Porter, Vip Viprakasit, Antonis Kattamis, Suporn Chuncharunee, Pranee Sutcharitchan, Noppadol Siritanaratkul, Renzo Galanello, Zeynep Karakas, Tomasz Lawniczek, Dany Habr, Jacqueline Ros, Yiyun Zhang, M. Domenica Cappellini Tags: Research Article Source Type: research

Among emergency physicians, use of the term “Sickler” is associated with negative attitudes toward people with sickle cell disease
(Source: American Journal of Hematology)
Source: American Journal of Hematology - May 13, 2013 Category: Hematology Authors: Jeffrey Glassberg, Paula Tanabe, Lynne Richardson, Michael DeBaun Tags: Correspondence Source Type: research

Concurrent polycythemia vera and chronic lymphocytic leukemia: Treatment response to pegylated interferon alpha 2a
(Source: American Journal of Hematology)
Source: American Journal of Hematology - May 13, 2013 Category: Hematology Authors: H. Andrew Selinger, Enrique Ballesteros, Robert Bona Tags: Correspondence Source Type: research